Etoposide-induced DNA damage in a chromosomal breakpoint of RUNX1 gene is independent of RUNX1 expression

Tammaro, 2013, Replication-dependent and transcription-dependent mechanisms of DNA double-strand break induction by the topoisomerase 2-targeting drug etoposide, PLoS One, 8, e79202, 10.1371/journal.pone.0079202 Ezoe, 2012, Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor, Int. J. Environ. Res. Publ. Health, 9, 2444, 10.3390/ijerph9072444 Zhang, 2002, Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia, Proc. Natl. Acad. Sci. USA, 99, 3070, 10.1073/pnas.042702899 Stuardo, 2009, Altered chromatin modifications in AML1/RUNX1 breakpoint regions involved in (8;21) translocation, J. Cell Physiol., 218, 343, 10.1002/jcp.21599 Yan, 2006, Histone H3 acetylation and H3 K4 methylation define distinct chromatin regions permissive for transgene expression, Mol. Cell Biol., 26, 6357, 10.1128/MCB.00311-06